CytoMed Therapeutics Ltd filed a report on June 20, 2024, announcing the resignations of Dr. Lucas Luk and Mr. Wu Tao as board members effective May 15, 2024, for personal reasons, with Dr. Luk continuing as Chief Clinical Officer. Dr. Loh Yuin Han has been appointed to the audit committee to maintain compliance with board requirements.